Sulzer (SUN) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
2 Feb, 2026Executive summary
Achieved strong H1 2024 results with order intake up 8.9% to CHF 2,079m and sales up 10.5% to CHF 1,992m, with all divisions and geographies contributing.
Profitability improved by 130 basis points year-over-year to 11.4%, with gross margin up 140 basis points to 33.7%.
Strategy 2028 implementation is underway, incurring some one-off operational costs but already contributing to improved margins and supporting ambitions for top industrial company status.
Net income increased 12.6% year-over-year to CHF 117.4 million; EPS rose to CHF 3.44.
2024 guidance for order intake raised to 9–12% and sales to 9–11% on continued market momentum.
Financial highlights
Order backlog as of June 30, 2024, was CHF 2,404.3 million, up 23.5% from December 2023.
EBIT rose approximately 20% year-over-year to CHF 170m, driven by higher sales and gross margins.
Free cash flow declined to CHF 55.4 million from CHF 106.6 million, mainly due to higher working capital and tax payments.
Net working capital as a percentage of sales decreased to 21.9% from 22.2% in H1 2023.
Net debt increased to CHF 226.0 million, up 31.2% from December 2023.
Outlook and guidance
Updated full-year guidance: order intake expected to rise 9–12%, sales up 9–11%, and EBITDA/EBITA margin around 12%.
No slowdown in order intake observed in July; strong project pipelines across divisions.
Net working capital targeted to be reduced by CHF 50 million by year-end.
Order book provides 4–6 months visibility overall, with some divisions up to 9 months.
Management expects continued growth in structurally expanding markets and strong execution in the second half.
Latest events from Sulzer
- Record sales, profit, and margins support a higher dividend and positive 2026 outlook.SUN
Q4 202526 Feb 2026 - Targets above-market growth, >17% EBITDA margin, and >22% ROCE by 2028, fully self-financed.SUN
CMD 20241 Feb 2026 - Double-digit sales and order growth, higher margins, and strong 2025 outlook driven by backlog.SUN
H2 202416 Dec 2025 - Order intake recovers, Services grow double digits, Chemtech hit by delays; guidance reaffirmed.SUN
Q3 2025 TU2 Nov 2025 - Sales, EBITDA, and net income up; Chemtech lagged, outlook and dividend increased.SUN
H1 202524 Jul 2025 - Stable Q1 order intake and confirmed guidance, with strong Flow and Services growth.SUN
Q1 2025 TU23 Jun 2025 - Order intake up 9.2% year-over-year; full-year guidance and profitability targets reaffirmed.SUN
Q3 2024 TU13 Jun 2025